Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ionis Pharmaceuticals Inc (IONS)  
$40.16 0.77 (1.88%) as of 4:30 Wed 5/8


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 143,470,000
Market Cap: 5.76(B)
Last Volume: 998,037 Avg Vol: 995,265
52 Week Range: $35.18 - $53.55
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  292
Guru Rank Value     : 4.1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ionis Pharmaceuticals is engaged in RNA-targeted therapeuty. Co.'s commercial products are SPINRAZA, TEGSEDI and WAYLIVRA. SPINRAZA injection for intrathecal use is a survival motor neuron-2 directed antisense medicine indicated for the treatment of spinal muscular atrophy in pediatric and adult patients. TEGSEDI injection is an RNA-targeted medicine indicated for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. WAYLIVRA is an antisense medicine indicated as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 11,298 469,764 507,366 634,895
Total Sell Value $477,835 $23,553,002 $25,162,121 $30,224,270
Total People Sold 4 12 13 13
Total Sell Transactions 4 44 52 78
End Date 2024-02-09 2023-11-08 2023-05-10 2022-05-10

   
Records found: 1983
  Page 2 of 80  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2024-02-01 4 A $0.00 $0 D/D 3,820 50,622     -
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2024-02-01 4 A $0.00 $0 D/D 4,140 95,030     -
   Bennett C Frank EVP, Chief Scientific Officer   •       –      –    2024-02-01 4 A $0.00 $0 D/D 3,609 80,932     -
   Swayze Eric EVP Research   •       –      –    2024-01-31 4 S $52.00 $560,196 D/D (10,773) 32,516 20%     
   Monia Brett P Chief Executive Officer   •       •      –    2024-01-25 4 S $51.75 $118,249 D/D (2,285) 151,851 21%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2024-01-25 4 S $51.75 $333,788 D/D (6,450) 46,802 21%     
   Monia Brett P Chief Executive Officer   •       •      –    2024-01-17 4 S $50.42 $1,616,319 D/D (32,059) 154,136 20%     
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2024-01-17 4 S $50.42 $390,429 D/D (7,744) 53,252 20%     
   Bennett C Frank EVP, Chief Scientific Officer   •       –      –    2024-01-17 4 S $50.42 $340,063 D/D (6,745) 77,323 20%     
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2024-01-17 4 S $50.42 $28,435 I/I (564) 1,640 20%     
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2024-01-17 4 S $50.42 $73,609 D/D (1,460) 12,799 20%     
   Geary Richard S EVP, Chief Development Officer   •       –      –    2024-01-17 4 S $50.42 $369,960 D/D (7,338) 85,475 20%     
   Birchler Brian EVP, Corp and Development Ops   •       –      –    2024-01-17 4 S $50.42 $226,725 D/D (4,497) 44,582 20%     
   Swayze Eric EVP Research   •       –      –    2024-01-17 4 S $50.42 $454 I/I (9) 85 20%     
   Swayze Eric EVP Research   •       –      –    2024-01-17 4 S $50.42 $317,425 D/D (6,296) 43,289 20%     
   Schneider Eugene EVP, Chf Clinical Develop Ofcr   •       –      –    2024-01-17 4 S $50.42 $276,386 D/D (5,482) 47,850 20%     
   Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc   •       –      –    2024-01-17 4 S $50.42 $280,520 D/D (5,564) 33,810 20%     
   Hougen Elizabeth L EVP, Finance & CFO   •       –      –    2024-01-17 4 S $50.42 $437,771 D/D (8,683) 90,890 20%     
   Monia Brett P Chief Executive Officer   •       •      –    2024-01-16 4 OE $0.00 $0 D/D 68,084 186,195     -
   Oneil Patrick R. EVP CLO & General Counsel   •       –      –    2024-01-16 4 OE $0.00 $0 D/D 20,641 60,996     -
   Bennett C Frank EVP, Chief Scientific Officer   •       –      –    2024-01-16 4 OE $0.00 $0 D/D 18,314 84,068     -
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2024-01-16 4 OE $0.00 $0 I/I 1,353 2,204     -
   Baroldi Joseph EVP, Chief Business Officer   •       –      –    2024-01-16 4 OE $0.00 $0 D/D 3,688 14,259     -
   Geary Richard S EVP, Chief Development Officer   •       –      –    2024-01-16 4 OE $0.00 $0 D/D 19,852 92,813     -
   Birchler Brian EVP, Corp and Development Ops   •       –      –    2024-01-16 4 OE $0.00 $0 D/D 12,080 49,079     -
  1983 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 80
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us